Hyperammonemia in neonates and infants causes irreversible damages in the developing CNS due to brain cell loss. Elucidating the mechanisms triggering ammonia-induced cell death in CNS is necessary for the development of neuroprotective strategies. We used reaggregated developing brain cell cultures derived from fetal rat telencephalon exposed to ammonia as an experimental model. Ammonia induced neuronal and oligodendroglial death, triggered apoptosis and activated caspases and calpain. Probably due to calpain activation, ammonia caused the cleavage of the cyclin-dependent kinase 5 activator, p35, to p25, the cdk5/ p25 complex being known to lead to neurodegeneration. Roscovitine, a cdk5 inhibitor, protected neurons from ammonia-induced cell death. However, roscovitine also impaired axonal growth, probably through inhibition of the remaining cdk5/p35 activity, which is involved in neurite outgrowth. Thus, cdk5 appears as a promising therapeutic target for treating hyperammonemic newborns and infants, especially if one develops specific cdk5/p25 inhibitors.
Introduction
Hyperammonemia in neonates and infants is mainly due to defects of the urea cycle enzymes or other inborn errors of metabolism, and causes irreversible damages in the developing CNS such as cortical atrophy, ventricular enlargement, demyelination, and hypodensities of gray and white matter. Irreversible lesions occur in prolonged hyperammonemia and/or high blood ammonia levels (for recent reviews see Cagnon and Braissant, 2007; Gropman et al., 2007) . The recent use of alternative-pathway therapies detoxifying ammonia improved the survival of patients (Enns et al., 2007) . However, the improved survival was correlated with a worsened neurological and cognitive outcome. Thus, the development of neuroprotective therapeutics is crucial for the improvement of the neurological outcome of neonates and infants experiencing hyperammonemia.
Ammonia induces cell death in primary cultures of neurons (Klejman et al., 2005) , but not of astrocytes (Widmer et al., 2007) , if ammonia exposure remains in pathophysiologically relevant concentrations (up to 5 mM). Moreover, we previously showed that ammonia inhibits axonal outgrowth (Braissant et al., 2002) . Mechanisms of ammonia cytotoxicity include NMDA excitotoxicity, oxidative stress, cerebral energy deficit, alteration of nitric oxide synthesis, and induction of mitochondrial permeability transition (for a review, see Cagnon and Braissant, 2007) . Elucidating the precise molecular mechanisms triggering ammonia-induced brain cell death will allow to identify new therapeutic targets.
Caspases are cysteine proteases playing key roles in apoptosis (Rupinder et al., 2007) . Caspases-3 and -9, as well as the dephosphorylation of the pro-apoptotic protein Bad, have been shown to be involved in ammonia-induced apoptosis of hippocampal neurons in primary cultures (Yang et al., 2003 (Yang et al., , 2004 . Other proteases such as calpain also contribute to apoptosis (McCollum et al., 2002) , and calpain activation is involved in various neurological disorders such as ischemia, ethanol neurotoxicity, as well as Alzheimer's and Parkinson's diseases (Mouatt-Prigent et al., 1996; Blomgren et al., 2001; Rajgopal and Vemuri, 2002; Raynaud and Marcilhac, 2006) . Moreover, calpain activation is responsible for the cleavage of p35 to p25, which are both activators of the cyclin-dependent kinase 5 (cdk5) (Lee et al., 2000) . In neurons, cdk5/p35 promotes survival and neurite outgrowth while cdk5/p25 induces neuronal death through an abnormal activation of cdk5 (O'Hare et al., 2005) . It was shown that pharmacological inhibitors of calpain can prevent p35 cleavage and the subsequent neuronal death (Lee et al., 2000) .
The aim of the present work was to test whether caspases, calpain, and cdk5/p25 were involved in ammonia-induced death of developing brain cells, and if so, whether inhibiting these death-promoting proteins could protect brain cell survival. For this purpose, we used reaggregated developing brain cell cultures derived from fetal rat telencephalon treated with ammonia as an experimental model for the developing brain exposed to hyperammonemia (Honegger and 
